Metronidazole Noridem

Metronidazole, the active ingredient in Metronidazole Noridem, is a nitroimidazole presented as an intravenous solution for injection use. It treats anaerobic bacterial infections and certain protozoal diseases in adult and pediatric patients when oral therapy is unsuitable or rapid systemic action is required.

GNH USA supplies Metronidazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support safe import and distribution through its global logistics network.

Metronidazole is used to treat infections caused by anaerobic bacteria and certain protozoa. - Anaerobic bacterial infections: eradicates infection by targeting anaerobic organisms. - Bacterial vaginosis: restores normal vaginal flora by eliminating pathogenic anaerobes. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing recurrence. - Intra‑abdominal infections: controls mixed aerobic‑anaerobic infections within the abdominal cavity. - Pelvic inflammatory disease: treats anaerobic components of PID, reducing inflammation and complications.

Metronidazole may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient alteration of taste perception. - Headache: occasional mild to moderate headache. - Diarrhea: loose stools that may be self‑limiting.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate attention. - Severe allergic reaction (anaphylaxis): rapid onset of rash, swelling, and breathing difficulty. - Stevens‑Johnson syndrome: severe skin and mucous membrane involvement. - Neutropenia: marked reduction in white blood cells. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Peripheral neuropathy: numbness or tingling in extremities.

Use Metronidazole with appropriate clinical monitoring. - Assess renal function: adjust use in severe renal impairment. - Monitor liver enzymes: exercise caution in hepatic disease. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Use with caution in pregnancy: risk unknown, weigh benefits against potential harm. - Avoid concurrent alcohol: may cause a disulfiram‑like reaction. - Store at ambient temperature: keep in original container, protect from light and moisture.

Metronidazole can interact with several medicines.

Major Interactions (Avoid): - Alcohol: may cause severe nausea, vomiting, and flushing. - Warfarin: potentiates anticoagulant effect, increasing INR and bleeding risk. - Lithium: may raise lithium concentrations, risking toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: can increase metronidazole plasma levels. - Phenobarbital: may reduce metronidazole efficacy. - Erythromycin: may increase risk of neurotoxicity.